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Lymphocytes express two types ofTCRs, either a/f (1-3) or y/b (4). The genes
encoding theTCR y and b chains are composed of V, D, J, andC regions that un-
dergosomatic rearrangement during development (5, 6) . There areonly eightfunc-
tional Vy gene segments and perhaps 5-10 functional VS gene segments identified
inhumans (6) . While the specificity ofthe TCR- ,y/b is poorly understood, thelimited
germline diversity suggested thatTCR-y/b-bearing lymphocytesmight recognize an-
tigen in the context of relatively nonpolymorphic antigen-presenting molecules (6) .
Recently, alloreactiveTCR- ,y/b cells specific forMHC class I and class II gene prod-
ucts, as well as class I-like gene products (Tla and Qa), have been described (7-9).
The distinct nature ofthe TCR-y/b, the fact that lymphocytes that bear it frequently
lack CD4 and CD8, and the non-MHC-restricted recognition oftumor targets by
some TCR-,y/b cells (10), led us to suggest that these TCRs might recognize cell
surface molecules not encoded in theMHC (10) . It was recently demonstrated that
ahuman TCR-,y/bclonecan recognizenon-MHC-encoded CD1 antigens that might
serve as novel antigen-presenting molecules for CD4 -8- T cells (11) . In addition,
some of the specific antigens that y/b T cells can recognize have been identified,
such as mycobacterial antigens (including heat-shock-proteins) (12-16) and tetanus
toxoid (17) . TCR-,y/6' lymphocytes expand markedly in number in lymphoid
organs and in tissue lesions in response to the mycobacterial antigens (13, 15) .
TCR- ,y/b cells comprise ti5% (0.5-20%) of the CD3+ cells in human peripheral
blood and in lymphoid tissues (18-20) . However, in mice, TCR- ,y/b cells preferen-
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tially localize and constitute the predominant subset at epithelial surfaces, such as
in the skin (dendritic epidermal cells [dEC]') (21) and in the intestine (intraepithelial
lymphocytes [IEL]) (22, 23). dEC express a single Vy/Vb pair (Vy3/Vbl) and have
very limited diversity at their V(D)J junctions, resulting in a population of T cells
that express virtually identical receptors in this location (24). In contrast, gut IEL
express predominantly two different Vy/VS pairs (V75/V64 or Vy5/V66) and have
much greater junctional diversity (23). In the mouse thymus, Vy and VS gene rear-
rangements appear in a sequential order (25). This ordered pattern in development
may account for the nonrandom expression of specific pairs of Vy and VS gene seg-
ments observed at different anatomical sites. Alternatively, or in addition, various
types of thymic selection, differential homing, or peripheral expansion might influence
the V gene pairs utilized and their peripheral locations. The site-specific localization
of y/b T cells bearing certain V gene pairs and the differences in diversity of the
junctional regions has led to the hypothesis that each cell population might perform
distinct functions related to their anatomical site.
In humans, the marked epithelial localization seen in the mouse has not been
observed (18). However, the relatively small percentage ofTCR'Y/b cells in gut were
noted preferentially to localize to the epithelium rather than the lamina propria in
one study (26) . Yet, selective Vy and VS gene pairing and differences in V gene
usage at various anatomical sites have been observed in man. The Vy2/VS2 chain
pair occurs in most individuals on >70% of the circulating y/b T cells (27, 28). In
contrast, VS1' cells are prevalent in late fetal and postnatal thymus and in the red
pulp of spleen (28, 29). To gain insight into the differential TCRy/b variable chain
usage in thymus compared with peripheral blood, in this report, both thymic and
extrathymic influences on the TCR-7/6 repertoire were studied. The results provide
evidence that a marked extrathymic expansion of y/6 T cells bearing certain V gene





mAbs used were SPVT3b (anti-CD3) (30), antiTCR-S1 (pan-reactive antiTCR-
b) (31), 6TCSI (anti-V61-J61, which appears to represent the most frequent V61 rearrange-
ment expressed in peripheral blood) (29, 32), BB3 (anti-V62) (33, 34), antiTiya (antiVy2
[alsocalled Vy9, for nomenclature see reference 6]) (35), anti-CyMl (pan-reactive antiTCRy)
(36), BMA 031 (pan-reactive antiTCR-a/O; kind gift of Dr. Kurrle at Behringwerke AG,
Marburg, FRG), and UCHLI (anti-CD45RO) (37). Isotype-matched mAbs that do not react
with human leukocytes were used as controls.
In Vitro TranscriptionlTranslation.
￿
A truncated TCR-S insert was prepared from the IDP2
TCRS cDNA clone (38) containing sequences downstream of the FnuD II site at the codon
encoding amino acid 106 in the D region . The truncated CS insert was ligated into the vector
pSP73 downstream from the SP6 promoter to yield the pSP73.Cb. In this construct, the first
methioninecodon is at amino acid residue 138 within the constant region ofthe TCRS chain.
Therefore, in vitro transcription and translation ofthis construct should yield a protein that
only includes amino acids encoded by the CS gene segment. Constructs encoding the full-
length IDP2-b protein (pGEM3-0240/38) and the IDP2 y protein (pSP65 .IDP2y) have been
' Abbreviations used in this paper: CBL, umbilical cord blood lymphocytes; CBMC, cord blood
mononuclear cells; dEC, dendritic epidermal cells; IEL, intraepithelial lymphocytes.PARKER ET AL.
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described previously (31, 39). These three cDNA constructs were linearized with appropriate
restriction endonucleases, transcribed, and translated in vitro. The resulting protein prod-
ucts were then immunoprecipitated utilizing mAb anti-C-yM1, antiTCR-81, and an IgGI
isotype-matched control antibody.
Immuno.luorescence Analysis ofCell Suspensions.
￿
Heparinized blood was obtained from um-
bilical cords of uncomplicated deliveries at the Brigham and Women's Hospital. Cord blood
mononuclear cells (CBMC) were isolated by centrifugation at 1,340 g with 45% sepracell-
MN (Sepratech, Oklahoma City, OK), 55% cord blood. When necessary, residual RBC were
lysed with ammonium chloride (40). PBMC from peripheral blood were isolated using Ficoll-
Paque (Pharmacia Fine Chemicals, Uppsala, Sweden). Thymocyte suspensions were pre-
pared by gently teasing thymic tissue into single cell suspensions using the entire lobule to
ensure that cortical and medullary thymocytes were accurately represented. Tonsil-derived
lymphocytes were prepared by gently teasing entire tonsil tissue into a single cell suspension.
For single-color analysis thymocytes, PBMC, CBMC, or tonsillar lymphocytes were re-
suspended at 2-4 x 106 cells/ml in staining buffer (PBS/5% human serum/1% BSA/0.02%
NaN3) containing saturating amounts of mAbs and incubated for 1 h at 4°C. After three
washes with staining buffer, cells were incubated with FITC-labeled F(ab')2 goat anti-mouse
Ig (TagoInc., Burlingame, CA). Two-color staining was performed using unconjugated mAbs
followed by FITC-conjugated goat anti-mouse Ig, then followed by an incubation with
saturating amounts of normal mouse serum. Biotin-conjugated mAbs followed by PE-con-
jugated streptavidin (Becton Dickinson & Co., Mountain View, CA, or Tago Inc.) were used
as the second-step reagents. Labeled cells were analyzed with either a Facscan flow cytometer
(Becton Dickinson & Co.) or Epics C (Coulter Electronics Inc., Hialeah, FL).
T Cell Lines.
￿
PBMC from a normal donor were isolated by density gradient centrifuga-
tion with Ficoll-Paque (See above). The PBMC were depleted of cdo T cells by incubation
with antiTCR-a/(3 (BMA 031) followed by goat anti-mouse Ig-conjugated magnetic beads
(M450; Dynal, Oslo, Norway). Cells with attached beads were removed by adherence to a
magnet. TCRa/l3-depleted lymphocytes were then enriched for TCR-y/b cells by incubation
with the panreactive antiTCR-y/b antibody (antiTCR61) followed by incubation with the
goat anti-mouse Ig-conjugated magnetic beads and magnet selection. The y/6 T cell-en-
riched line was cultured with irradiated PBL feeder cells and maintained in culture by peri-
odic restimulation with PHA as previously described (4). After 4 wk ofculture, the cells in
this line stained homogeneously with the pan-reactive TCR-y/b mAb; 7.6% of the cells in
this line stained with the V61-specific mAb and 93.5% stained with the V52-specific mAb.
Positive selection with an anti-CD8 mAb (OKT8) and magnetic beads produced a homogene-
ously V61' cell line. In long-term culture, >99% of the lymphocytes in the OKT8-selected
line were positive with the antiV61 mAb, and >99% ofthe lymphocytes in the original TCR
y/b-enriched line were reactive with the anti-V62 mAb.
Results
Anti-7CR61 mAb Recognizes a Cb-encoded Determinant.
￿
Four mAbs directed against
distinct TCRy/b determinants were utilized. mAb MCS1 detects a Vbljbl-encoded
determinant (called anti-V61 in this study) (29, 32), mAb BB3 (detects a V62-encoded
determinant (antiV62) (33, 34), and antiTiyA detects a Vy2-encoded determinant
(antiVy2) (35). In addition, mAb antiTCR-61 has broad reactivity against y/6 T
cells and is thought to be panreactive. Here, a cDNA construct was transcribed and
translated in vitro to produce a protein product including only the C region of the
TCR6 protein, and this protein product was recognized by the antiTCR-61 mAb
(Fig. 1). This demonstrates directly that the antiTCR-61 mAb recognizes a deter-
minant in the Cb-encoded portion of the TCR 6 chain and thus should recognize
all TCR-6-bearing lymphocytes (See Materials and Methods, and Fig. 1).
Age-related Changes in TCR-y/6 V Gene Usage in the Periphery.
￿
Seven umbilical cord
blood samples and 27 thymi were analyzed for y/6 T cell number and variable chain1600
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mAbimmunoprecipitated the in vitro
translated productwhose synthesiswas
directed by a full-length TCR6 con-
struct (seeTCR6 construct panel) . To
determine ifthis mAb reacted with a
determinant in the constant region of
the S chain, in vitro transcription and
translation ofa truncatedC6construct
was performed to produceaC region
peptide. The antiTCR61 mAbimmu-
noprecipitated this C region peptide
(see C6 construct panel) . Isotype-
matched controlmAb and anti-CyMl
(antiTCR-y) mAb failed to recognize
these 6 chain-encoded products . The
antiTCR-y mAbdid immunoprecip-
itate the protein product oftheTCRy
construct (seeTCRy construct panel),
whileantiTCR61 did notimmunopre-
cipitate the TCRy protein product.
Thus, antiTCR-61 reacts specifically
with adeterminant encoded in theC6
region oftheTCR6 protein, indicating
that it should be reactive with all TCR-6-
bearing T cells (see Materials and
Methods for experimental details) .
usage. The TCR-y/6V gene usage in cord blood and in thymus was quite similar,
but differed from adult peripheral blood . Cord bloodTCRy/S cells used predomi-
nantly V61-encoded products (50% of y/6 T cells) and less frequently expressed
V62-encoded products (25% of y/S T cells) . Similarly, in the thymus, V61 expres-
sion was predominant as it was found on 65% of the y/6 T cells, while VS2 was
expressed on only 10-15% of thymic y/S T cells . In contrast to thymus and cord
blood, adult (>21 yr old) peripheral bloodV gene usage was characterized by pre-
dominant expression of V62-encoded subunits (>70% of y/ST cells), while asmaller
number of cells bore V61-encoded receptors (on <30% of y/6T cells) in most indi-
viduals . In addition, the proportion of T cells expressing TCRy/S in cord blood
was quite similar in all the individuals tested (mean of 1.73% [SEM = 0.18] of
CD3 ` cells), and was on average threefold lower than the proportion ofT cells ex-
pressing TCRy/6 in adult peripheral blood (5.7% [SEM = 1.4] of CD3+ cells) .
These preliminary studies thus confirmed earlier reports (19, 20, 29) showing that
a difference existed between y/SV gene usage in thymic and peripheral locations .
Furthermore, theobservation that peripheral umbilical cord blood at birth was similar
to thymus, but distinct from adult peripheral blood suggested the existence of a
significant age-related extrathymic expansion o£ circulating 'r/6T cells associated
with a change in the predominant V genes they expressed . This observation was
examined in detail here .
The proportion of T cells expressing y/6 TCRs (antiTCR61 +) gradually rose
from a mean of 1.73% of the T cells at birth, to a mean of 10% of the T cells at
6 yr of age, after which the mean fell to a lower level, with a wide range ofindividual
values in adulthood (Fig . 2 A, top) . Variable gene segment usage was analyzed inPARKER ET AL. 1601
FIGURE 2 . (A) Age-related
variation in the percentageofT
cells expressing TCRy/4 VS1,
or VS2 in human peripheral
blood . The percentage of pe-
ripheral blood CD3' cells ex-
pressing TCR-y/b (antiTCR
bl*), VSl (STCS-1'), and V62
(BB3') was determined by
single-color FACS analysis (see
Materials and Methods), and
plotted versus age. Umbilical
cord blood is represented by
open triangles adjacent to the
y-axis (these values were tightly
grouped so that many open tri-
angles are overlaying one an-
other), and samples from chil-
dren and adults are represented
by open squares . The lines on
the plots were generated using
a lowess smoother computer
analysis (f = 0.2) (51) . The per-
centage of cells positive for a
givenmAbwas calculatedusing
the formula: 100 x (percent of
PBL positive with mAb shown
on they axis/percent of PBL
positive with mAb SPVT3b) .
(B) Age-related variation in the
percentage of y/b T cells that
bear V61- or V62-encoded
receptors in peripheral blood .
The percentage of peripheral
blood antiTCR-bl' cells ex-
pressing Vbl or VS2 was deter-
mined by single-color FACS
analysis and plotted versus age .
Umbilical cord blood determi-
nations are represented by open
triangles adjacent to they-axis,
child and adult samples by open
squares . The lines on the plots
were generated using a lowess
smoother computer analysis (f
= 0.5) (51). Percentage of cells
positive for a given mAb was
calculated using the formula:
100x (percent ofPBL positive
with mAbshownon they-axis/
percent of PBL positive with
antiTCR-S1) .1602
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these individuals by staining with anti-V61 and anti-V62 mAbs. During this time
period, the proportion of T cells expressing Vbl remained nearly constant while
the percentage of T cells expressing Vb2 increased strikingly (Fig. 2 A, middle and
bottom). In addition to the age-related increase in the number of y/b T cells, a shift
from a V61 predominance to a VS2 predominance over the first 6 yr of life was also
observed (Fig. 2 B, top and bottom). Thus, both the increase in cell number (Fig.
2 A) and the change in V gene predominance (Fig. 2 B) could be accounted for
by an age-related expansion of the V62-bearing T cell subset.
V32 Expansion in the Periphery Occurs in the Absenceofa Parallel Thymic Wave.
￿
Toad-
dress whether a postnatal thymic wave of TCR V62-expressing cells could explain
the rising number ofV62-bearing cells in the periphery with advancing age, 29 thymi
between 3 wk and 8 yr of age were examined by FACS staining for TCRy/b cell
number and V gene segment expression. In addition, paired samples of peripheral
blood were obtained at the same point in time from 18 of these individuals and ana-
lyzed for TCR-,y/b cell number and V gene segment expression. In contrast to the
peripheralblood where an age-related increase in the proportion ofT cellsexpressing
the TCR-y/b was observed (Fig. 2 A, top), in the thymus, the proportion of T cells
expressing the TCR-y/b remained constant with increasing age, up to the age of
8 yr. This resulted in a rise in the ratio of T cells expressing TCRy/b in the periph-
eral blood compared with the thymus in the paired thymus/peripheral blood samples
over time (Fig. 3 A). In addition, thymus samples showed no change in the per-
centage of TCR--y/b cells bearing either Vbl- or V62-encoded receptors over time.
In none of the thymi did we observe >30% Vb2+ cells (mean = 12%), including
thymi from individuals in whom the Vb2 expansion (often to >85% of the y/b cells)
had already occurred in the paired peripheral blood sample (Fig. 3 B). Since the
percentage of y/b T cells and usage of V gene segments was unchanged over time
for all thymus samples examined, no evidence to support the occurrence of a post-
natal thymic wave of V62-bearing cells was found. Instead, it seemed more likely
that the expansion ofTCR-y/b cells bearing Vb2 in the periphery may have resulted
from a postnatal extrathymic expansion of this subset, while the V61-bearing cells
remained constant in number.
Age-related Expression ofCD45RO on M52-bearing Cells.
￿
The CD45 transmembrane
protein is found on all T cells and occurs in distinct isoforms as a result of alterna-
tively spliced exons (41). The smallest isoform, CD45RO, lacks all of the differen-
tially spliced exons and is recognized by mAb UCHLI (42). Nearly all T cells(>95%)
from neonatal peripheral blood are negative or express only low levels of CD45RO
(43, 44). With increasing age, the percentage of T cells that express high levels of
CD45RO rises until -60To of all of the circulating T cells are UCHLIh` in adult-
hood (43). A similar rise has also been demonstrated for y/b T cells in peripheral
blood (43). To confirm that both Vbl + and Vb2 + y/b T cells were capable of ex-
pressing CD45RO after activation, in vitro cultured cell lines expressing these V
genes were examined by FACS analysis; which revealed that both expressed increased
levels of CD45RO. The Vb2+ line expressed CD45RO at high levels, while Vbl
cell lines expressed CD45RO at moderate levels. In addition, both Vb1- and V62-
expressing thymocytes and tonsil-derived lymphocytes expressed moderate or high





















































(A) Age-related change in the TCR- ,y/S percentage in thymus compared with pe-
ripheral blood . The percentage ofCD3' (SPVT3b') cells expressing TCR-y/S (antiTCRSl')
in thethymus and in peripheral blood in the same individual at thesame point in time was deter-
mined . The ratio of the TCRy/S percentage in thymus compared with peripheral blood was
calculated using the formula: (percent ofPBL positive with mAb antiTCR-S1/percent ofPBL
positive withmAbSPVT3b)/(percent of thymocytes positive withantiTCRSl/percent ofthyrtto-
cytes positive with SPVT3b). The line on the plot was generated usinga lowess smoother com-
puteranalysis (f = 0.5) (51). (B) Age-relatedchange inTCRS variable gene segmentusinginthymus
compared with peripheral blood . The percentage of CD3' (SPVT3b') cells expressing VSl
(STCS-1', top) or VS2 (13133', bottom) in the thymus and in peripheral bloodwasdetermined by
single-color FRCS analysis and plotted versus age. Peripheral blood determinations are repre-
sented by solid symbols whilethymus determinations are displayed asopen symbols. Circles rep-
resent thymus samples withoutapaired peripheral blood sample. Triangles represent paired samples
of thymus and peripheral blood obtained from the same individual at the same point in time.
Thepercentage ofcells positive with agivenmAbwas calculated as in Fig . 2A . Computer-generated
lines reveal age-related trends .1604
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Since an increase in expression of CD45RO occurs when naiveT cells are acti-
vated, this antigen may serve as a differentiation marker for previously activated
or"memory"T cells (44, 45) . We therefore examined whether theexpansion ofV62-
bearing cells observed here (Fig. 2 A, bottom) correlated with expansion of naive
(CD45RO- or CD45RO10) or of previously activated (CD45ROh') cells . In umbil-
ical cord blood lymphocytes(CBL), two populationsof lymphocyteswere observed,
one that was unreactive (CD45RO-) and one that was weakly reactive (CD45RO'O)
with UCHLI mAb (Fig . 4 A) . Very few (<5%) of neonatal T cells stained brightly
with UCHLI. On PBL from children of increasing age, a third population of cells
was observed that stained brightly (CD45ROh') . The CD45RO 10 population was
small in adult PBL, while the CD45ROht population predominated (Fig . 4 A) . In
two-color FAGS analysis, both Vbl + andVb2 +Tcells in umbilical cord blood lacked
the CD45ROht phenotype . By 1 yr of life, CD45ROh' was expressed on -30% of
the TCR- ,y/b* cells . This percentage continued to rise between 1 and 18 yr of life
to rti60% of the VS2* cells, suggesting that a significant proportion of these cells
were previously activated (Fig . 4 B) . In contrast to Vb2* lymphocytes, Vbl+ lym-
phocytes remained <20% CD45ROh' even in adulthood (Fig . 4 B) . Moreover, no
shift from CD45RO- to CD45RO`0 could be identified on V61-bearingT cells from
children ofincreasing age(through age 18) (datanot shown) . Thus, a striking differ-
100
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(A)CD45ROexpression onPBL . CD45RO expression was analyzed onPBL at birth
(cord blood), from a 6-yr-old child, and from an adult . The 6-yr-old child's profile was utilized
to set cursors dividing the PBL into populations with negative (CD45RO-), low (CD45ROI°),
or high (CD45ROh') expression of CD45RO determined by staining with mAb UCHLI and
one-color FACS analysis . (B) CD45RO h ' expression of Vbl- or V62-bearing T cells in periph-
eral blood . The percentage ofVbl` or VS2* -y/bT cells that expressCD45ROh ' wasdetermined
by two-colorFACS analysis onCBL (trianglesadjacent to they-axis) andonPBL (circles) and plotted
versus age . Vbl* y/b cells (6TCS1*, open symbols) rarely express CD45ROh ', while VS2* 'Y/b T
cells (BB3*, closed symbols) showed an age-related increase in the percentage that express
CD45ROh' . The percentage of Vbl* or VS2* cells that express CD45ROh' was determined in
two-color FACS analysis by gating on the cells positive with the V&specificmAband then deter-
mining the percentage of the gated cells that were in each of the three regions ofUCHLI staining
determined in Fig. 4A. The percentage of cells expressingCD45ROh ' was calculated using the
formula : number ofV61' or VS2* cells in the CD45ROh ' region/total number of Vbl * or VS2*
cells . The lines on the plot were generated usinga lowess smoothercomputer analysis (f = 0.5) (51) .ence existed in peripheral blood between the Vb2+ TCRy/b cells, which expanded
in an age-related fashion and expressed s phenotype characteristic of "memory
T cells"' and the Vbl+ cells, which failed to expand in number or to express this
memory phenotype. Acquisition of the memory phenotype on Vb2+ y/b T cells oc-
curred during the ageperiod in which theproportion ofTCR-y/bcells bearingVb2
in peripheral blood was increasing (compare Fig. 2 B, bottom, with Fig. 4 B), sug-
gesting that the increase in cell number might be related to activation and prolifera-
tion of these cells.
Individual Variation in TCR-y/S V Gene Repertoire.
￿
The observations noted above
apply to the population of individuals in general. It has been reported that in most
adults, >70% of the TCRy/b repertoire in peripheral blood can be accounted for
by a single Vy2/VS2 chain pair (46) . The analysis here confirmed this generaliza-
tion, but also identified a number of subjects who displayed a different pattern of
expression of Vy and Vb genes in their peripheral blood. Four representative ex-
amples ofhealthyadults with differingTCRb V gene-defined phenotypes are shown
(Fig. 5). In peripheral blood from subject 1, Vb2 was expressed on 947o of the -Y/6
cells, with V61 expressed on nearly all the remainingTCRy/b cells. In this individual,
Vb2 was paired predominantly with Vy2, while V61 was almost never paired with
Vy2. This corresponds to the predominant phenotype previously reported by others
(46). In subject 2, Vb2 was expressed on 77% of the y/b T cells; the majority of
the remaining y/b cells expressed Vbl. Like subject 1, Vb2 paired predominantly
with Vy2; in contrast to subject 1, V61 paired with Vy2 on N60% of Vb1+ T cells.
Subjects 3 and 4 differed strikingly from subjects 1 and 2 since VS2 expression was
found on only 40 and 7% of the peripheral blood y/b T cells, respectively.
Correspondingly, in these latter subjects V61 expression predominated and was
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Vy andVS gene segment usage
differs in four adultindividuals.TCRy/bvari-
able chain usage was determined on the pe-
ripheral bloodoffour individualsby two-color
FRCS analysis. Foreach individual, the per-
centage of y/6Tcellsexpressing V61 or Vb2
is represented by theheight ofthebar. Ofthe
cells that express either V6l or V62, the
proportion that pairswith Vy2 is represented
by thepartofthebarthat is shaded. Note that
both theproportion ofcellsthat express each
VS gene segment andthefrequencyofpairing
ofVy2with Vbl vary strikingly from subject
to subject. Vbl, Vb2, and Vy2 were detected
with mAbs STCSI, BB3, and Tiya, respec-
tively. The percentage of CD3' cells positive
for the VS chains was calculated as in Fig. 2
A. The percentage of Vbl' or VS2' cells
positive with antiVy2 was calculated from
two-color FRCS by gating on thecells stained
with either anti-V61 (6TCSI) or anti-V82
percentage ofthe gated cells that were positive with the antiVy2
or VS2' cellsexpressing Vy2 was calculated using the formula:
Vy2' region/total number of Vbl' or VS2' cells.1606
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ofindividuals, Vb2 usage predominated (subjects 1 and 2), while in the other cases,
Vbl and VS2 were used about equally or V61 predominated (the least frequent oc-
currence) (subjects3 and 4, respectively) . Thus, while the majority ofTCR-'y/b cells
in all subjects expressed either Vbl or VS2, the relative proportion of cells that ex-
pressed each of theseTCR b chains varied . To confirm that an individual measure-
ment in aperson reflected a stable phenotype, four adults were examined on at least
four occasions over a period of 18 mo . These analyses revealed a modest variation
over time in the percentage ofT cells expressing TCR- ,y/4 but no significant varia-
tion in the relative expression and pairing of Vb1, Vb2, and Vy2 . This suggested
that the TCR-y/b repertoire in adults is relatively stable over a period ofmonths
to years .
The y/b Gene Repertoire Is Not Solely Determined by Inherited Factors .
￿
To determine
if background genetic differences could account for the distinct ,y/b V gene reper-
toires observed amongindividuals, family and twin studieswere performed . In family
1 (Fig . 6 A), both parents expressed a less common phenotype, in which Vb1 gene
segment usage predominates over Vb2 gene segment expression (>50% V61, <30%
Vb2) . However, all of thechildren displayed thecommon phenotype, expressing Vb2
on >70% of their TCR-y/b cells . Thus, none of the progeny displayed the parental
y/b phenotype, despite the fact that each MHC haplotype carried by the parents
was inherited by at least one of the children . In family 2 (Fig . 6 B), one parent ex-
FIGURE 6 .
￿
V6 gene usage in families. VB gene usage was determined for the members of two
families, as described in Fig . 4 . The extendedMHC haplotypes are represented within the circles
or squares by A, B, C, andD . The histogram represents TCRy/b cells, the lowest (solid) section
represents the proportion ofTCRy/6 cells expressing V61 gene segments, the middle (shaded)
section represents the proportion of TCR-y/6 cells expressing the V62 gene segment, and the
top (open) section represents the proportion of TCR-y/b cells expressing neither V61 nor V62
gene segments (VBX) . The ages of family 1 (A) members 1, 2, 3, 4, 5, and 6 are 62, 68, 34,
36, 42, and 33 yr, respectively, and the percents ofCD3' cells expressingTCRy/6 are 1.13, 4.12,
2.78, 3.69, 8.48, and 10.64%, respectively . MHC haplotypes in family 1 are (A) A2, B5, DR5 ;
(B) Aw24, B39, DR7 ; (C) Aw31, B7, DR4; and (D)Al, B41 . Individual 6 hasjuvenile rheumatoid
arthritis . The ages of family 2 (B) members 1, 2, 3, 4, and 5 are 69, 69, 39, 43, and 24 yr, respec-
tively, and the percents of CD3' cells expressing TCR-y/b are 17.64, 0.60, 4.80, 2.51, and 2.71%,
respectively. MHC haplotypes in family 2 are (A) A3, B14, DR6, DQwl ; (B) A2, B60, DR4 ;
(C) A32, B60, C3, DR4 ; and (D) A29, B44, DR7, DQw2 . Individual 2 has rheumatoid arthritis .pressed V61 on 40% of the y/S cells while the other parent expressed VSl on 11%
of the y/b T cells . Interestingly, two of the progeny of this pair (subjects 3 and 4)
inherited identicalMHC haplotypes, yet were markedly different from each other
in theirexpression ofTCR- ,y/b variable gene segments . Individual 3 expressed VS2
on >90% and V61 on very fewofthey/bT cells. In contrast, individual 4 expressed
VS2 on only 27% and VS1 on -25% of the TCR-,y/b cells . These representative
family studies reveal no simple or direct correlation between inheritanceofaMHC
haplotype and TCR- ,y/b phenotype in PBL. This suggested that factors other than
theMHC type must influence TCR- ,y/b V gene usage by peripheral bloodT cells .
Thesemayinclude othergenetic factors not encoded in theMHC, or environmental,
influences .
To address whether other genetic elements besides those encoded in theMHC
might determine the TCR-y/SV gene repertoire, seven sets of identical twins were
evaluated (Fig. 7) . In four sets, both twinsshowed nearly identical'y/SV gene reper-
toires, expressing the common phenotype with VS2 on a majority of their .y/S T
cells. However, several sets revealed divergent V gene usage . In both twin sets A
and B, one individual utilized VS1 on -25% of they/ST cells in peripheral blood,
while the other individual utilized VS1 on <10% of they/ST cells. The twins also
differed in VS2 usage, since one member of twin setA utilized VS2 on 85% of the
y/S T cells, while the other individual utilized VS2 on 60% of the y/S T cells. Set
B differed more dramatically in V82 usage; one individual expressed V62 on 30%
of the y/ST cells, while the other individual expressed V62 on 93% of the y/S T
cells . In each twin set, individual 1 has diabetes mellitus and individual 2 is healthy .
However, it does not appear that the disease accounts for these differences in the
expression ofVS gene segments, as the VSI usage is high in the diabetic individual
of one twin set, but in the nondiabetic individual ofthe othertwin set . The different
TCR-y/6V gene repertoire in the peripheral blood of such identical twins supports
the hypothesis that therearenongenetic influences that affect TCR'r/Svariable chain
expression on peripheral blood T cells .
Discussion
The repertoire ofTCR-y/S variable gene segments expressed on lymphocytes in










































V6 gene segment usage in iden-
tical twins. Histograms for individuals 1 or
2 ofeach set oftwins (A and B) show the per-
centage ofy/b T cells that use Vbl (left, solid)
or V62 (right, open) . Note that the scale of the
left panel and the right panel aredifferent . In-
dividual 1 has diabetes mellitus, while in-
dividual 2 is healthy in both twin sets A and B.1608
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cord) at birth. However, with increasing age, the number of TCR-y/6-bearing T
cells in peripheral blood increased during the first 6 yr of life and then fell slightly.
This rise was accounted for by an increase in the number of V62 expressing TCR
y/6 cells in peripheral blood, resulting in the previously described predominance
of TCRy/6 cells bearing VS2 in adult PBL (27, 28). However, the number of V61-
bearing cells in peripheral blood did not change with age. Therefore, the ratio of
V32/V61-bearing cells rose dramatically after birth until about age 6. During the
period when theV62 number in PBL increased, no change in V&encodedgene seg-
ment expression was observed in thymus samples, including determinations per-
formed on paired human thymus and peripheral blood samples from the same donor.
The average ratio of V62/V61 as well as the proportion of T cells expressing TCR
y/6 remained stable in the thymus at all ages studied, making it unlikely that adis-
tinct thymic wave of cells bearing V62-encoded receptors occurred at the time of
the observed increase in peripheral VS2' cells. On the other hand, a correlation
existed between the rising number of VS2' cells and their high levels of expression
of CD45RO. Taken together, the absence of a distinct VS2' postnatal thymic wave
and the CD45RO phenotype supports the hypothesis that the age-related changes
in peripheral blood TCRy/6 V gene repertoire are accounted for by extrathymic
events, possibly antigen exposure. The peripheral population ofVS2' T cells is poly-
clonal, since all of the genes analyzed from peripheral blood PCR (18/18 V62' VJC
junctions) (47) or Southern blot analysis (four of four clones from each of two indi-
viduals) (29) showed distinct sequences or gene rearrangements. The fact that the
V62 expansion(and preferential chain pairing) did not occurequally in individuals
andthat these differences could notbe accounted forin an inherited fashion in fami-
lies or identical twins suggested further that these individual variations might result
from nongenetic environmental antigen or superantigen challenges. In otherstudies,
expansion of T cells bearing specific VR gene segments have been noted in vitro
afterstimulation with staphylococcal toxins (48). In addition, T cellsexpressing specific
V6 gene segments have been shown to proliferate in response to mycobacterial an-
tigens (12). Thus, antigens like these might account fortheexpansion ofV62-expressing
y/6 T cells and their high levels of expression of CD45RO in peripheral blood.
However, it is likely that a number of factors may play a role in determining the
V6 repertoire. For example, selective homing could influence the V gene repertoire
at each anatomical site as recent studies in both mice and man suggest that V gene
usage varies at distinct anatomical sites. Similarly, TCR Vy- andV&encoded chain
pairs may interact with distinct ligands in different tissues and be expanded on that
basis. In this study, V61' T cells in the periphery expressed a naive phenotype. It
is possible that these V61' cells may then migrate to localized sites where they are
activated, as is thought to occur for lymphocytes in general (49). Interestingly, in
previous studies, VSl' lymphocytes have been shown to be present at twofold
greater frequency than VS2' T cells in the human intestinal epithelium (50). In
contrast to normal individuals, in patients with coeliac disease, the proportion of
IEL T cells expressing V61 is increased by more than fivefold, while the proportion
of T cells expressing V62 is unchanged (50). This suggests that V61' T cells might
be stimulated preferentially in this location in contrast to the reciprocal expansion
of VS2' cells that occurs in the peripheral blood pool as shown in this report . In-
formationemerging from other studies hassuggested an important role fordevelop-PARKER ET AL.
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mentally regulated TCR gene rearrangements in determining the TCR-y/b reper-
toire (25). The data presented here point to the importanceofextrathymic peripheral
expansion of selected y/b subsets, in generating the adult TCR-,y/b repertoire.
Summary
The germline repertoire of variable genes for the TCR-,y/b is limited. This, to-
gether with the availability of several Vb-specific and a Cb-specific mAbs, has made
it possible to assess differences in the TCRy/b repertoire in man. TCR-,y/b cells
expressing particular V gene segments have been previously shown to be localized
in different anatomical sites. In this study, analysis ofTCRy/b V gene segment usage
performed on subjects from the time of birth through adulthood revealed striking
age-related changes in the TCR-y/b repertoire in peripheral blood. Vbl + y/b T cells
predominated in thymus as well as in peripheral blood at birth and then persisted
as a relatively constant proportion of CD3 + PBL. However, Vb2+ y/b T cells that
constitute a small proportion of the CD3+ cells in thymus and in peripheral blood
at birth, then expand and account for the major population of y/b T cells in PBL
in adults. No parallel postnatal expansion ofVb2+ cells in the thymus was observed,
even when paired thymus-peripheral blood specimens were obtained on subjects be-
tween the ages of 3 d and 8 yr. The subset of Vb2+ lymphocytes that was expanded
in peripheral blood expressed high levels of CD45RO suggesting prior activation
ofthese cells, consistentwith the possibility that their expansion might have resulted
from exposure to foreign antigens or superantigens. In contrast, Vbl+ T cells in
PBL showed no comparable increase in relative numbers and were either negative
or expressed only low levels of CD45RO. Consistent with evidence for extrathymic
peripheral expansion of selective TCR-,y/b subsets, no link between MHC haplo-
type and differences in the TCR-y/b V gene usage between individuals was apparent,
and identical twins displayed TCR-,y/b variable gene segment phenotypes that were
strikingly different from one another.
The elements that determine the TCRy/b repertoire in individuals are not known.
It is possible that both thymic selection and extrathymic factors may influence the
peripheral repertoire. Recently, TCRy/b+ lymphocytes have been shown to expand
markedly in peripherallymphoid tissues and infectious lesions in response to mycobac-
terial antigens (13, 15), and a correlation between mycobacterial responses and TCR-,y/b
V gene usage has been shown in mice (12). The data presented here demonstrated
peripheral age-related changes in the y/b repertoire and point to the importance
of extrathymic expansion of specific y/b subsets in generating the human TCRy/b
repertoire.
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